Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131...
Designation Supported by CLOVER WaM Phase 2 Study DataWhich Reported an 83.6%...
Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough...
Company Expands IP Portfolio While Advancing Clinical Innovation in Oncology Supportive Care Case Study and Interim Clinical Trial Results...
Novel FDA-Approved Treatment Options for NMIBC
The treatment landscape for high-risk, BCG-unresponsive non–muscle-invasive bladder cancer has expanded significantly, with 3 FDA-approved bladder-sparing therapies now available: pembrolizumab, nadofaragene firadenovec (Adstiladrin), and...
Breakthrough tumor profiling study offers hope for more precise skin cancer...
Every tumor is unique. This makes it difficult to find the most...
Israeli researchers help achieve breakthrough in myeloma treatment
Researchers presented the findings this week at the American Society of Clinical Oncology’s annual meeting in Chicago and published them simultaneously in the Journal...
Breakthrough discovery offers new hope for treatment of memory loss due...
A new understanding of Alzheimer’s disease is shaking up what many believed about how this devastating illness takes hold. Once thought to be driven...
Behind gene editing breakthroughs are families who say yes
Recent headlines told a story that once was science fiction: A child received a groundbreaking in vivo gene editing treatment, a one-time infusion designed to rewrite...
Breakthrough drug therapy offers new hope for leukemia patients
Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the U.S. and Europe are...
Shapeshifting bowel cancer cells key to treatment breakthrough
Aggressive bowel cancer cells can “shapeshift” to mimic skin or muscle to enable the disease to spread around the body, research has revealed.The changes...
